molecularbrain.com Report : Visit Site

Technical data of the molecularbrain.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host molecularbrain.com. Currently, hosted in United States and its service provider is Tiggee LLC .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Oscar Platform 201802052158-178 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

skip to content advertisement menu explore journals get published about bmc login my account search search all bmc articles search molecular brain menu home about articles submission guidelines search submit a manuscript featured article: criteria for identifying the molecular basis of the engram (camkii, pkmzeta) in 2016 john lisman accepted an invitation from the editors of molecular brain to contribute an article to our series of mini-reviews on molecules of memory. we received his article on 'criteria for identifying the molecular basis of the engram (camkii, pkmzeta)’ in september 2017 and it went out to referees in the usual way. in october 2017, before the review process was complete, we heard the sad news of john’s death. as a tribute to his outstanding theoretical and experimental contributions to many aspects of brain function, but particularly to the understanding of the neural basis of learning, we are publishing his paper as submitted. we hope to publish a collection of commentaries on his paper at a later date. featured image rong wu et al. schematic representation of the role of trem2 in cerebral ischemia/reperfusion injury (figure 8) read this article articles recent most accessed content type: research | 28 june 2018 nmda receptor antagonists attenuate intrathecal morphine-induced pruritus through erk phosphorylation authors: le shen, weijia wang, siyu li, jing qin and yuguang huang content type: research | 20 june 2018 rnaseq analysis of hippocampal microglia after kainic acid-induced seizures authors: dale b. bosco, jiaying zheng, zhiyan xu, jiyun peng, ukpong b. eyo, ke tang, cheng yan, jun huang, lijie feng, gongxiong wu, jason r. richardson, hui wang and long-jun wu content type: research | 7 june 2018 nodding behavior couples to vigilance fluctuation in a high-calorie diet model of drowsiness authors: anna shin, jeonghoon woo, jung eun kim and daesoo kim content type: short report | 4 june 2018 excitation wavelength optimization improves photostability of asap-family gevis authors: fang xu, dong-qing shi, pak-ming lau, michael z. lin and guo-qiang bi content type: research | 1 june 2018 gabaergic deficits and schizophrenia-like behaviors in a mouse model carrying patient-derived neuroligin-2 r215h mutation authors: dong-yun jiang, zheng wu, cody tieu forsyth, yi hu, siu-pok yee and gong chen most recent articles rss view all articles content type: review | 14 may 2012 the molecular biology of memory: camp, pka, cre, creb-1, creb-2, and cpeb authors: eric r kandel content type: review | 7 january 2011 app processing in alzheimer's disease authors: yun-wu zhang, robert thompson, han zhang and huaxi xu content type: review | 22 january 2013 expression of nmda receptor-dependent ltp in the hippocampus: bridging the divide authors: tim vp bliss and graham l collingridge content type: review | 13 may 2010 emotional enhancement of memory: how norepinephrine enables synaptic plasticity authors: keith tully and vadim y bolshakov content type: research | 1 march 2013 synaptic potentiation in the nociceptive amygdala following fear learning in mice authors: ayako m watabe, toshitaka ochiai, masashi nagase, yukari takahashi, masaru sato and fusao kato most accessed articles rss view all articles article collection - molecules of neural disorders in this series of reviews, we take a look at the molecular basis of neural disorders. the topics addressed include: ipsc technology for autism models, camkii dysregulation in alzheimer's disease, migroglia in neuropathic pain, metabotropic glutamate receptors in schizophrenia, and cortical kinate receptors in anxiety. aims and scope molecular brain is an open access, peer-reviewed journal that considers manuscripts on all aspects of studies on the nervous system at the molecular, cellular, and systems level providing a forum for scientists to communicate their findings. molecular brain research is a rapidly expanding research field in which integrative approaches at the genetic, molecular, cellular and synaptic levels yield key information about the physiological and pathological brain. these studies involve the use of a wide range of modern techniques in molecular biology, genomics, proteomics, imaging and electrophysiology. no major experimental revisions requested. we will not request major additional experiments during the peer-review process, as we believe that high-quality data should be published promptly without unnecessary delay. latest tweets about the society molecular brain is the official journal of the association for the study of neurons and diseases (and). the and is a not-for-profit organization for the study of mental health from a neurological perspective. the goal of and is to enhance the quality and quantity of research and education as it pertains to the understanding and treatment of mental health issues. editors' quotes “the brain is the most complex structure in the universe, yet it defines who we are. molecular brain is a fast, open access, online journal that publishes high quality papers and thus promotes communication among neuroscientists interested in revealing the mysteries of brain function at the molecular and cellular level." bong-kiun kaang, editor-in-chief, molecular brain “it is our goal at molecular brain to offer a rapid and open access forum for papers that illuminate the molecular mechanisms underpinning the cellular, network and cognitive aspects of brain function. there is no field in 21st century science that is advancing with such astonishing rapidity, and we hope that molecular brain will reflect this excitement.” tim bliss, editor-in-chief, molecular brain "one of the most significant driving forces in science is discovery in our daily research activity. at molecular brain , we believe the delay between the moment of discovery and publication should be as short as possible, but with high-quality and fair peer-review. by exploring and adopting new innovations and technology advances, i will strive to ensure molecular brain is the best place to publish your discovery in brain science. " tsuyoshi miyakawa, editor-in-chief advertisement submit a manuscript editorial board sign up for article alerts and news from this journal affiliated with ​​​​​​​ molecular brain is affiliated with the association for the study of neurons and disease (and). 2016 journal metrics speed 18 days from submission to first decision 9 days from acceptance to publication citation impact 3.410 - 2-year impact factor 4.096 - 5-year impact factor 0.994 - source normalized impact per paper (snip) 1.910 - scimago journal rank (sjr) usage 269,790 downloads 917.0 usage factor social media impact 134 mentions more about our metrics molecular brain is a member of the neuroscience peer review consortium. molecular brain has partnered with publons to give you official recognition for your contribution to peer review. create a free profile to have your reviews automatically added. follow follow us on twitter advertisement molecular brain issn: 1756-6606 contact us submission enquiries: [email protected] general enquiries: [email protected] explore journals get published about bmc read more on our blogs receive bmc newsletters manage article alerts language editing for authors scientific editing for authors policies accessibility press center contact us leave feedback careers follow bmc bmc twitter page bmc facebook page bmc google plus page bmc weibo page by using this website, you agree to our terms and conditions , privacy statement and cookies policy. manage the cookies we use in the preference centre. © 2018 biomed central ltd unless otherwise stated. part of springer nature .